A study for the coronavirus drug in the UK revealed that an inexpensive and easy-to-access drug called ‘dexamethasone’ could assist in the treatment of COVID-19 patients.
In the context of combating the coronavirus outbreak, vaccination and drug studies carried out all over the world continue without slowing down. The coronavirus, which has cost the lives of more than 437 thousand people, continues its effects all over the world. Finally, Pascal Soriot, CEO of AstraZeneca, has made some statements regarding coronavirus vaccine today. Pascal Soriot said that the vaccine, which they expect to act for 1 year, will be sold for 2 euros.
Today, a study to explore coronavirus drug in the UK revealed that a new drug can be used in the treatment of patients with COVID-19. According to the information, experts stated that low-dose steroid therapy can play a big role in the fight against coronavirus. As a result of the drug research conducted under the leadership of Oxford University, it was observed that this drug named ‘dexamethasone’ reduced the risk of death by one third in patients connected to the respiratory device.
If ‘dexamethasone’ was used at the very beginning of the treatment, the lives of 5,000 people in the UK could have been saved:
According to experts, dexamethasone has been available in the UK since the outbreak began, and 5,000 people in the UK would have survived COVID-19 if this drug could be discovered earlier and used on patients. It is also thought that the drug can be very useful in the fight against coronavirus in poor countries due to its availability and cheapness. Dexamethasone, which affects patients in the high-risk group, can also prevent some of the damage in the weakened immune system when trying to cope with the coronavirus.
In dexamethasone trials, 2,000 patients who received coronavirus treatment in the hospital were given this drug and the results were compared with the data of 4,000 patients who did not take the drug. In the resulting results, the risk of death of patients connected to the respiratory device, given dexamethasone, decreased from 40% to 28%. Experts state that dexamethasone is the first drug that can reduce the risk of death in COVID-19 disease. The head of the research delegation. “This is the only drug that has reduced the mortality rate so far. It significantly reduces the mortality rate. This is a great result.” Experts also warn that this cytokine storm can result in death.